QuickView for peptide transmembrane transporter activity (biogroup)

1. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
2. Neural development of iPSCs derived from Autistic patients with BCKD-kinase mutations
3. L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens
4. miRNA expression in childhood adrenocortical tumors
5. L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens

There were no matches for peptide transmembrane transporter activity

1. Aerosolized Hypertonic Xylitol Versus Hypertonic Saline in Cystic Fibrosis (CF) Subjects
2. Inhaled Xylitol Versus Saline in Stable Subjects With Cystic Fibrosis
3. Real Life Evaluation of the Multi-organ Effects of Lumacaftor/Ivacaftor on F508del Homozygous Cystic…